A Retrospective, National, Multicenter Study Evaluating the Impact of Ulipristal Acetate (Esmya®) on Infertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques (ART)
Phase of Trial: Phase IV
Latest Information Update: 16 Jan 2019
At a glance
- Drugs Ulipristal (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- Acronyms NACRE
- 08 Jan 2019 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 17 Jul 2018 Planned End Date changed from 30 Jun 2018 to 31 Aug 2018.